Antiobesity Effect of a Novel Herbal Formulation LI85008F in High-Fat Diet-Induced Obese Mice
A variety of natural products have been explored for their antiobesity potential and widely used to develop dietary supplements for the prevention of weight gain from excess body fat. In an attempt to find a natural antiobesity agent, this study was designed to evaluate the antiobesity activity of a...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/6612996 |
id |
doaj-97189aa092dc4aab9188f4e0568d30dd |
---|---|
record_format |
Article |
spelling |
doaj-97189aa092dc4aab9188f4e0568d30dd2021-02-22T00:01:57ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-42882021-01-01202110.1155/2021/6612996Antiobesity Effect of a Novel Herbal Formulation LI85008F in High-Fat Diet-Induced Obese MiceHak Joo Choi0Hwa Young Kim1Kyoung Sik Park2Food Test and Research CenterJu Yeong NS Co., LtdDepartment of Biomedical ScienceA variety of natural products have been explored for their antiobesity potential and widely used to develop dietary supplements for the prevention of weight gain from excess body fat. In an attempt to find a natural antiobesity agent, this study was designed to evaluate the antiobesity activity of a novel herbal formulation LI85008F composed of extracts from three medicinal plants in high-fat diet- (HFD-) induced obese mice. After the thirteen-week oral administration of the test materials to mice, the body weight gain, whole-body fat mass, adipose tissue weight, and the expression levels of obesity-related proteins were measured. Our results indicated that LI85008F can suppress body weight gain and lower whole-body fat mass in HFD-induced obese mice. Significant decreases in epididymal and retroperitoneal fat mass were observed in LI85008F-treated groups compared with the HFD-fed control group (p<0.05). Furthermore, the oral administration of LI85008F caused significant decreases in the expression level of adipogenic (C/EBPα and PPARγ) and lipogenic (ACC) markers and notable increases in the production level of thermogenetic (AMPKα, PGC1α and UCP1) and lipolytic (HSL) proteins. These findings suggest that LI85008F holds great promise for a novel herbal formulation with antiobesity activities, preventing body fat accumulation and altering lipid metabolism.http://dx.doi.org/10.1155/2021/6612996 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hak Joo Choi Hwa Young Kim Kyoung Sik Park |
spellingShingle |
Hak Joo Choi Hwa Young Kim Kyoung Sik Park Antiobesity Effect of a Novel Herbal Formulation LI85008F in High-Fat Diet-Induced Obese Mice Evidence-Based Complementary and Alternative Medicine |
author_facet |
Hak Joo Choi Hwa Young Kim Kyoung Sik Park |
author_sort |
Hak Joo Choi |
title |
Antiobesity Effect of a Novel Herbal Formulation LI85008F in High-Fat Diet-Induced Obese Mice |
title_short |
Antiobesity Effect of a Novel Herbal Formulation LI85008F in High-Fat Diet-Induced Obese Mice |
title_full |
Antiobesity Effect of a Novel Herbal Formulation LI85008F in High-Fat Diet-Induced Obese Mice |
title_fullStr |
Antiobesity Effect of a Novel Herbal Formulation LI85008F in High-Fat Diet-Induced Obese Mice |
title_full_unstemmed |
Antiobesity Effect of a Novel Herbal Formulation LI85008F in High-Fat Diet-Induced Obese Mice |
title_sort |
antiobesity effect of a novel herbal formulation li85008f in high-fat diet-induced obese mice |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-4288 |
publishDate |
2021-01-01 |
description |
A variety of natural products have been explored for their antiobesity potential and widely used to develop dietary supplements for the prevention of weight gain from excess body fat. In an attempt to find a natural antiobesity agent, this study was designed to evaluate the antiobesity activity of a novel herbal formulation LI85008F composed of extracts from three medicinal plants in high-fat diet- (HFD-) induced obese mice. After the thirteen-week oral administration of the test materials to mice, the body weight gain, whole-body fat mass, adipose tissue weight, and the expression levels of obesity-related proteins were measured. Our results indicated that LI85008F can suppress body weight gain and lower whole-body fat mass in HFD-induced obese mice. Significant decreases in epididymal and retroperitoneal fat mass were observed in LI85008F-treated groups compared with the HFD-fed control group (p<0.05). Furthermore, the oral administration of LI85008F caused significant decreases in the expression level of adipogenic (C/EBPα and PPARγ) and lipogenic (ACC) markers and notable increases in the production level of thermogenetic (AMPKα, PGC1α and UCP1) and lipolytic (HSL) proteins. These findings suggest that LI85008F holds great promise for a novel herbal formulation with antiobesity activities, preventing body fat accumulation and altering lipid metabolism. |
url |
http://dx.doi.org/10.1155/2021/6612996 |
work_keys_str_mv |
AT hakjoochoi antiobesityeffectofanovelherbalformulationli85008finhighfatdietinducedobesemice AT hwayoungkim antiobesityeffectofanovelherbalformulationli85008finhighfatdietinducedobesemice AT kyoungsikpark antiobesityeffectofanovelherbalformulationli85008finhighfatdietinducedobesemice |
_version_ |
1714852951088955392 |